Liminatus Pharma Shares Hit New Peak Post Nasdaq Approval Investors React Positively After Listing Status Restored Liminatus Pharma Inc. (NASDAQ: LIMN) witnessed an impressive rally in its share price on June 5, 2025, reaching an all-time high of \$28.80. This … Continue reading Liminatus Pharma Shares Hit New Peak Post Nasdaq Approval